Plandai Biotechnology Inc represents values of innovation, sustainability, and scientific excellence. With a mission to provide natural and effective health solutions, the company focuses on utilizing its proprietary technology to extract beneficial compounds from plants. Plandai Biotechnology Inc believes in promoting human health while minimizing environmental impact through the production of high-quality botanical extracts. By integrating science and nature, Plandai Biotechnology Inc is committed to developing groundbreaking products that contribute to overall well-being. Through continuous research and development, the company aims to revolutionize the healthcare industry and enhance the lives of individuals worldwide.

Plandai Biotechnology Inc is primarily present in the United States, South Africa, and Australia.

Some of the significant milestones achieved by Plandai Biotechnology Inc include the successful implementation of its proprietary Phytofare® Catechin Complex extraction process, which enables the company to produce superior bioavailable products. Furthermore, Plandai Biotechnology Inc has secured partnerships and licensing agreements with leading companies to expand its market presence and distribution network. The company has also made progress in conducting clinical trials to demonstrate the effectiveness and safety of its products. Additionally, Plandai Biotechnology Inc has received recognition for its innovative approach to plant bioactives and its commitment to sustainable farming practices.

Plandai Biotechnology Inc is a company specializing in the research, development, and production of plant-based botanical extracts for the health and wellness industry. Founded in 2012, Plandai Biotechnology has since emerged as a leader in phytochemical research and extraction technology. The company's focus lies in harnessing the medicinal and health benefits of phytochemical compounds derived from specific plants, such as green tea and citrus fruits. With a commitment to sustainable practices and innovative solutions, Plandai Biotechnology is dedicated to bringing novel, science-based products to the market that promote overall well-being.

The main competitors of Plandai Biotechnology Inc in the market include companies like TherapeuticsMD Inc, Celgene Corporation, and GW Pharmaceuticals Plc.

Plandai Biotechnology Inc is primarily active in the biotechnology industry.

Plandai Biotechnology Inc is engaged in the development, licensing, and commercialization of highly bioavailable plant extracts for the nutraceutical and pharmaceutical industries. The company's business model focuses on leveraging its proprietary extraction processes to create sustainable, bioactive ingredients from botanical sources. Plandai Biotechnology's advanced plant extraction technology ensures the maximum retention of active compounds, leading to enhanced therapeutic benefits. By partnering with leading global companies, Plandai Biotechnology aims to expand its product portfolio and penetrate new markets. Through its innovative business model, Plandai Biotechnology Inc strives to revolutionize the nutraceutical and pharmaceutical sectors with its scientifically-backed, high-quality plant extracts.

KGV kan i øjeblikket ikke beregnes for Plandai Biotechnology.

KUV kan i øjeblikket ikke beregnes for Plandai Biotechnology.

AlleAktien Kvalitetsscore for Plandai Biotechnology er 4/10.

Omsætningen kan i øjeblikket ikke beregnes for Plandai Biotechnology.

Overskuddet kan i øjeblikket ikke beregnes for Plandai Biotechnology.

Plandai Biotechnology Inc. is an innovative biotechnology company that focuses on the development of plant extracts and bioactive compounds. The company operates in various business areas, including the production of dietary supplements and cosmetic products, as well as the development of pharmaceutical agents. The core of Plandai Biotechnology Inc.'s business model lies in a deep understanding of the unique properties of plants and their potential to develop innovative products. The company operates agricultural farms in South Africa and the USA to cultivate plants that are rich in bioactive compounds. The main products of Plandai Biotechnology Inc. include plant extracts from Rooibos, green tea, and cannabis. These extracts are used in a variety of products, including dietary supplements, cosmetic skincare products, and pharmaceutical drugs. Dietary supplements and cosmetic products Plandai Biotechnology Inc. offers a wide range of dietary supplements and cosmetic products based on the unique properties of plant extracts. These products are formulated naturally and free from artificial additives and chemicals. They are primarily sold online and through selected retailers. One example of a dietary supplement is Phytofare® Catechin Complex, which contains extracts from green tea. The product is rich in antioxidants and helps support the immune system and improve overall well-being. One example of a cosmetic product is Phytofare® Botanical Face Cleanser, which contains Rooibos extracts and other natural ingredients. This cleanser is gentle on the skin and helps improve skin appearance by reducing inflammation and providing antioxidant benefits. Pharmaceutical products Plandai Biotechnology Inc. is working on developing pharmaceutical products based on plant extracts and bioactive compounds. The company has already achieved success in various areas. For example, a cannabis formulation has been developed that meets specific pharmaceutical standards and has high bioavailability. This formulation can be used in the treatment of chronic pain, epileptic seizures, and other conditions. The company also aims to develop drugs to support the immune system, fight cancer, and treat Alzheimer's disease. Plandai Biotechnology Inc. works closely with universities and research institutions to fully harness the potential of plant biotechnology and create medical innovations. Conclusion Plandai Biotechnology Inc. is a key player in the biotechnology industry, bringing its products to market based on plant extracts and innovative compounds. The company also benefits from the growing demand for natural and healthy products that are highly effective with minimal side effects. With its close collaboration with research institutions and universities, Plandai Biotechnology Inc. has impressive expertise and is well-positioned to continue producing innovative products.

Plandai Biotechnology udbetaler et udbytte på 0 USD fordelt over udbetalinger om året.

Udbyttet kan for nuværende ikke beregnes for Plandai Biotechnology, eller selskabet udbetaler ikke udbytte.

ISIN'en for Plandai Biotechnology er US72703D1000.

WKN for Plandai Biotechnology er A1JSDB.

Tickeren for Plandai Biotechnology er PLPL.

I løbet af de sidste 12 måneder betalte Plandai Biotechnology en dividende på . Dette svarer til et dividendeudbytte på omkring . For de kommende 12 måneder vil Plandai Biotechnology sandsynligvis betale en dividende på 0 USD.

Udbytteafkastet for Plandai Biotechnology er i øjeblikket .

Plandai Biotechnology betaler kvartalsvis udbytte. Dette uddeles i månederne .

Plandai Biotechnology betalte udbytte hvert år i løbet af de sidste 0 år.

For de kommende 12 måneder forventes der dividender på 0 USD. Dette svarer til et dividendeafkast på 0 %.

Plandai Biotechnology bliver tildelt sektoren 'Sundhed'.

For at modtage det seneste udbytte på Plandai Biotechnology fra den 28.9.2024 på 0 USD, skulle du have haft aktien i din portefølje før ex-datoen den 28.9.2024.

Udbetalingen af det sidste udbytte blev foretaget den 28.9.2024.

I løbet af 2023 udbetalte Plandai Biotechnology 0 USD i form af dividender.

Udbytterne fra Plandai Biotechnology udbetales i USD.